Business News
-

HVAX Technologies Reports 35% Jump in Total Income for H1 FY26
Mumbai : HVAX Technologies Limited (NSE- HVAX | INE0TO501019), a specialized turnkey solutions provider in cleanroom and controlled environment infrastructure, has announced its Un-audited financial results for H1 FY26. H1 FY26 Key Financial Highlights Commenting on…
-

UPL Achieves Highest ESG Score in Dow Jones Sustainability Indices Among Agricultural Solutions Companies Globally
Mumbai : UPL, a global provider of sustainable agricultural solutions, has achieved the highest ESG score among agricultural solutions companies in the 2025 Dow Jones Sustainability Indices (DJSI) powered by S&P Global. UPL is the only…
-

Brace Port Logistics Posts Robust 11% EBITDA Margin for H1 FY26,Up 68 BPS YoY
Delhi : Brace Port Logistics Limited (NSE: INE0R4Z01018), one of the leading service-based logistics and supply chain solutions providers, announced its Unaudited financial results for H1 FY26. H1 FY26 Standalone Key Financial Highlights H1 FY26…
-

Capillary Technologies India Limited’s subscribed 28% on Day 1 of IPO
The Initial Public Offering of Capillary Technologies India Limited was subscribed 0.28 times on the first day of bidding, demonstrating strong demand from retail and non-institutional investors for this IPO. The issue received bids of 23,68,150 against the…
-

IWL reports its strongest ever second quarter performance
Mumbai: Inox Wind Limited (IWL), India’s leading wind energy solutions provider, announced today its financial results for the quarter ended September 30, 2025. Continuing on its robust growth journey, IWL delivered its best ever second…
-

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Ahmedabad, India : Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL…

